2012-09-18 07:54:08 - Recently published research from Global Markets Direct, "Pollen Allergy - Pipeline Review, H2 2012", is now available at Fast Market Research

Global Markets Direct's, 'Pollen Allergy - Pipeline Review, H2 2012', provides an overview of the Pollen Allergy therapeutic pipeline. This report provides information on the therapeutic development for Pollen Allergy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pollen Allergy. 'Pollen Allergy - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/463775_pollen_allergy_pipeline_review_h2_201 ..


Note*: Certain sections in the report may be removed or altered based on the availability

and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Pollen Allergy.
* A review of the Pollen Allergy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Pollen Allergy pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Pollen Allergy.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Pollen Allergy pipeline depth and focus of Pollen Allergy therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Pollen Allergy Therapeutic Products under Development, Key Players in Pollen Allergy Therapeutics, Pollen Allergy Pipeline Overview, Pollen Allergy Pipeline, Pollen Allergy Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Pollen Allergy Overview
Therapeutics Development
An Overview of Pipeline Products for Pollen Allergy
Pollen Allergy Therapeutics under Development by Companies
Pollen Allergy Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Pollen Allergy Therapeutics - Products under Development by Companies
Pollen Allergy Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Pollen Allergy Therapeutics Development
Merck & Co., Inc.
ALK-Abello A/S
Taiho Pharmaceutical Co., Ltd.
Allergy Therapeutics plc
Stallergenes S.A.
Allergopharma Joachim Ganzer KG
Circassia Holdings Ltd.
ImVisioN Therapeutics AG
Laboratorios LETI S.L.
ANERGIS SA
REGiMMUNE Corporation
Immunomic Therapeutics, Inc.
Biomay AG
Pollen Allergy - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Pollinex Quattro Japanese Cedar - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Sublingual MPL - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pollinex Quattro Tree - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pollinex Quattro Grass - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Pollinex Quattro Grass - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Allergen Extract Of Phleum Pratense - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Birch Pollen Allergoid - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MK-7243 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ToleroMune Grass Allergy T-cell Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Grazax - Drug Profile

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463775&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.